Zusammenfassung
Die Mitteilung der Diagnose Epilepsie und der Notwendigkeit einer langjährigen medikamentösen Therapie bedeutet für den Betroffenen und seine Familie ein einschneidendes Ereignis. Man muss sich vor Augen halten, dass die Eltern und die schon etwas älteren Patienten mit einem Begriff konfrontiert werden, mit dem sie keine genauen Vorstellungen verbinden; und wenn, dann überwiegend falsche, d. h. Schrecken und Angst erregende.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Aldenkamp AP, Arends J (2004) Effects of epileptiform EEG discharges on cognitive function: is the concept of »transient cognitive impairment« still valid? Epilepsy Behav 5(Suppl 1):S25–S34
Beume LA, Steinhoff BJ (2010) Long-term outcome of difficultto-treat epilepsy in childhood. Neuropediatrics 41:135–139
Brodie MJ, Yuen AW (1997) Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group. Epilepsy Res 26:423–432
Camfield P, Camfield C (2008) When is it safe to discontinue AED treatment? Epilepsia 49(Suppl 9):25–28
Chadwick D, Taylor J, Johnson T (1996) Outcomes after seizure recurrence in people with well-controlled epilepsy and the factors that influence it. The MRC Antiepileptic Drug Withdrawal Group. Epilepsia 37:1043–1050
Chaves J, Sander JW (2005) Seizure aggravation in idiopathic generalized epilepsies. Epilepsia 46(Suppl 9):133–139
Gayatri NA, Livingston JH (2006) Aggravation of epilepsy by anti-epileptic drugs. Dev Med Child Neurol 48:394–398
Genton P (2000) When antiepileptic drugs aggravate epilepsy. Brain Development 22:75–80
Hahn A, Fischenbeck A, Stephani U (2004) Induction of epileptic negative myoclonus by oxcarbazepine in symptomatic epilepsy. Epileptic Disord 6:271–274
König SA, Elger CE, Vassella F et al (1998) Recommendations for blood studies and clinical monitoring in early detection of valproate-associated liver failure. Results of a consensus conferences 09.05.–11.05.1997 in Berlin. Nervenarzt 69:835–840
Lerman-Sagie T, Watemberg N, Kramer U, Shahar E, Lerman P (2001) Absence seizures aggravated by valproic acid. Epilepsia 42:941–943
Lortie A, Chiron C, Mumford J, Dulac O (1993) The potential for increasing seizure frequency, relapse, and appearance of new seizure types with vigabatrin. Neurology 43(Suppl 5):S24–S27
McTague A, Appleton R (2011) Treatment of difficult epilepsy. Arch Dis Child 96:200–204
Prats JM, Garaizar C, García-Nieto ML, Madoz P (1998) Antiepileptic drugs and atypical evolution of idiopathic partial epilepsy. Pediatr Neurol 18:402–406
Ryvlin P (2006) When to start antiepileptic drug treatment: seize twice might not harm. Curr Opin Neurol 19:154–156
Sazgar M, Bourgeois BF (2005) Aggravation of epilepsy by antiepileptic drugs. Pediatr Neurol 33:227–234
Sirven JI, Sperling M, Wingerchuk DM (2001) Early versus late antiepileptic drug withdrawal for people with epilepsy in remission. Cochrane Database Syst Rev 3:CD00190–2
Stafstrom CE (2010) Mechanisms of action of antiepileptic drugs: the search for synergy. Curr Opin Neurol 23:157–163
Stephen LJ, Brodie MJ (2002) Seizure freedom with more than one antiepileptic drug. Seizure 11:349–351
Wirrell EC et al (1997) Long-term psychosocial outcome in typical absence epilepsy. Sometimes a wolf in sheeps' clothing. Arch Pediatr Adolesc Med 151:152–158
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Neubauer, B., Hahn, A. (2014). Medikamentöse Langzeittherapie von Epilepsien. In: Neubauer, B., Hahn, A. (eds) Dooses Epilepsien im Kindes- und Jugendalter. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-41954-6_19
Download citation
DOI: https://doi.org/10.1007/978-3-642-41954-6_19
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-41953-9
Online ISBN: 978-3-642-41954-6
eBook Packages: Medicine (German Language)